Kidney disease is a global public health problem, affecting over 750 million persons worldwide.1,2 The burden of kidney disease varies substantially across the world, as does its detection and treatment. In many settings, rates of kidney disease and the provision of its care are defined by socio-economic, cultural and political factors leading to significant disparities.3 World Kidney…
In a new study, patients with serum phosphate levels above 1.78 mmol/L at the start of peritoneal dialysis had a nearly 2-fold increased risk of death.
In a study, CKD patients with OSA treated with nasal continuous positive airway pressure (CPAP) had significantly higher eGFR after 12 months of treatment than those not receiving CPAP.
Laboratory testing for parathyroid hormone, phosphorus, 25-hydroxyvitamin D, and other biochemical markers of mineral bone disease falls short of 2012 KDIGO guidelines.
Longitudinal renal function trajectories may enable more individualized prediction of adverse outcomes, researchers conclude. Faster kidney disease progression is associated with an increased risk of adverse outcomes in patients with both atrial fibrillation (AF) and chronic kidney disease (CKD), new data suggest. In a study of 18,240 patients with AF and stage 3–4 CKD, each…
Sertraline is modestly more effective than cognitive behavioral therapy (CBT) in treating depressive symptoms in patients on maintenance hemodialysis (HD), new study findings suggest. The study, led by Rajnish Mehrotra, MD, MS, of the Kidney Research Institute at the University of Washington in Seattle, also found that engagement interviews had no effect on patient acceptance…
